Form DEF 14A Quince Therapeutics Inc For: 27 April
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Quince Therapeutics Inc (QNCX)
Track the Quince Therapeutics share price today and view real-time QNCX share price data, including charts, technicals, and key financials. View the QNCX premarket stock price ahead of the market session or assess the after hours quote. Explore QNCX stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Quince Therapeutics Stock Price Today?
The Quince Therapeutics stock price today is 1.330.
What Is the Stock Symbol for Quince Therapeutics?
The stock symbol for Quince Therapeutics is ""QNCX.""
What Stock Exchange Does Quince Therapeutics Trade On?
Quince Therapeutics is listed and trades on the NASDAQ stock exchange.
Is Quince Therapeutics a Good Stock to Buy?
Determining whether Quince Therapeutics or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the QNCX quote. (ISIN: US22053A2069)
What Is the Quince Therapeutics Stock Price Today?
The Quince Therapeutics stock price today is 1.330.
What Is the Stock Symbol for Quince Therapeutics?
The stock symbol for Quince Therapeutics is ""QNCX.""
What Stock Exchange Does Quince Therapeutics Trade On?
Quince Therapeutics is listed and trades on the NASDAQ stock exchange.
Is Quince Therapeutics a Good Stock to Buy?
Determining whether Quince Therapeutics or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the QNCX quote. (ISIN: US22053A2069)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.260
1.340
52 wk Range
0.800
45.499
QNCX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.2601.340
52 wk Range
0.80045.499
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
QNCX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
- Form 8K Quince Therapeutics Inc For: 9 April
- Investing.com
- Form 8K Quince Therapeutics Inc For: 30 March
- Investing.com
- Form 8K Quince Therapeutics Inc For: 22 April
- Investing.com
- Form DEF 14A Quince Therapeutics Inc For: 27 April
- Investing.com
- Form 8K Quince Therapeutics Inc For: 22 April
- Investing.com
- Form PRE 14A Quince Therapeutics Inc For: 17 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
0 Buy
3 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.000
Earnings
Latest Release
03/03/2026
EPS / Forecast
-1.75 / -0.18
Revenue / Forecast
-- / --
Compare QNCX to Peers and Sector
Metrics to compare | QNCX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQNCXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −3.2x | −0.5x | |
PEG Ratio | 0.01 | −0.08 | 0.00 | |
Price/Book | −0.6x | 3.8x | 2.6x | |
Price / LTM Sales | - | 35.9x | 3.2x | |
Upside (Analyst Target) | - | 81.8% | 48.1% | |
Fair Value Upside | Unlock | 0.5% | 6.6% | Unlock |
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient’s own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Quince Therapeutics (QNCX) Stock Price Today?
The Quince Therapeutics stock price today is 1.330 USD.
What Stock Exchange Does Quince Therapeutics Trade On?
Quince Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Quince Therapeutics?
The stock symbol for Quince Therapeutics is "QNCX."
What Is the Quince Therapeutics Market Cap?
As of today, Quince Therapeutics market cap is 21.680M USD.
What Is Quince Therapeutics's Earnings Per Share (TTM)?
The Quince Therapeutics EPS (TTM) is -16.763.
When Is the Next Quince Therapeutics Earnings Date?
Quince Therapeutics will release its next earnings report on 19/05/2026.
From a Technical Analysis Perspective, Is QNCX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Quince Therapeutics Stock Split?
Quince Therapeutics has split 1 times.
How Many Employees Does Quince Therapeutics Have?
Quince Therapeutics has 38 employees.
What is the current trading status of Quince Therapeutics (QNCX)?
As of 03/05/2026, Quince Therapeutics (QNCX) is trading at a price of 1.330 USD, with a previous close of 1.310 USD. The stock has fluctuated within a day range of 1.260 USD to 1.340 USD, while its 52-week range spans from 0.800 USD to 45.499 USD.
What Is the QNCX Premarket Price?
QNCX's last pre-market stock price is 1.270 USD. The pre-market share volume is 32,430.000, and the stock has decreased by -0.040, or -3.050%.
What Is the QNCX After Hours Price?
QNCX's last after hours stock price is 1.300 USD, the stock has decreased by -0.030, or -2.260%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.